𝔖 Bobbio Scriptorium
✦   LIBER   ✦

45 A first-in-patient clinical trial demonstrates that inhaled alginate oligosaccharide (OligoG) is well tolerated in cystic fibrosis (CF) patients

✍ Scribed by Walshaw, M.; McElvaney, G.; Williams, R.; Morice, A.; Carroll, M.; Haworth, C.; Herzig, M.; Ketchell, I.; Myrvold, R.; Meland, N.; Myrset, A.H.; Smerud, K.T.


Book ID
124103719
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
59 KB
Volume
13
Category
Article
ISSN
1569-1993

No coin nor oath required. For personal study only.